Treatment of Vaginal Dermatitis
The treatment of vaginal dermatitis should be based on the underlying cause, with topical corticosteroids and topical calcineurin inhibitors being the primary treatment options for most forms of vulvovaginal dermatitis. 1
Diagnosis and Classification
Before initiating treatment, it's crucial to identify the specific type of vaginal dermatitis:
- Contact dermatitis: Caused by irritants or allergens in products like soaps, detergents, lubricants, or medications
- Lichen simplex chronicus: Characterized by chronic itching and thickened skin from repeated scratching
- Lichen sclerosus: White, thin patches with skin atrophy
- Lichen planus: Purple, flat-topped lesions with potential erosions
- Desquamative inflammatory vaginitis: Characterized by vaginal rash and purulent discharge
Treatment Algorithm
First-line treatments:
For contact dermatitis:
For lichen simplex chronicus:
For desquamative inflammatory vaginitis:
Second-line treatments:
- Topical calcineurin inhibitors (pimecrolimus or tacrolimus) when:
- Patients are intolerant to corticosteroids
- Concerns about skin atrophy with prolonged corticosteroid use
- Resistance to corticosteroid treatment 5
Special Considerations
Duration of treatment:
Pregnancy:
Condom compatibility:
- Oil-based creams and suppositories may weaken latex condoms and diaphragms 1
- Use water-based alternatives when barrier contraception is needed
Potential Pitfalls
Misdiagnosis: Symptoms can mimic other conditions; confirmation with microscopy or culture may be necessary before treatment 1
Inadequate treatment duration: Especially for chronic conditions, premature discontinuation can lead to treatment failure 1
Ignoring underlying causes: For contact dermatitis, treatment will fail if the allergen exposure continues 2
Relapse risk: In desquamative inflammatory vaginitis, 32% of patients relapse within 6 weeks after stopping treatment 4
Follow-up Recommendations
- Schedule follow-up visits if symptoms persist or recur within 2 months of initial treatment 1
- For chronic conditions, regular monitoring is needed to assess treatment response and adjust therapy as needed
- For desquamative inflammatory vaginitis, long-term follow-up is essential as only 26% achieve cure at 1 year 4